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  Calcium-deficient hydroxyapatite (HA) granules with a unique spherical shape were 
prepared using an applied hydrothermal method.  Spherical stoichiometric HA granules 
were also prepared by normal sintering and both granules were used for implantation into 
rat tibiae to compare the biological responses to each implant.  Twelve and 24 weeks after 
implantation, the volume of calcium-deficient HA granules was significantly less than that 
of stoichiometric HA granules, and the biodegradability of calcium-deficient HA granules 
was confirmed.  The larger number of osteoclasts, larger osteoblast surface and larger 
bone volume in the implanted area of calcium-deficient HA than of stoichiometric HA 
suggested that osteoclastic resorption of calcium-deficient HA affected osteogenesis in that 
area.  To analyze the direct contribution of osteoclasts to osteogenesis, C2C12 multipotent 
myoblastic cells, which have the potential to differentiate into osteoblasts in the presence of 
bone morphogenetic protein 2, were cultured with supernatants of osteoclasts cultured on 
calcium-deficient HA, stoichiometric HA, β-tricalcium phosphate disks or plastic dishes, or 
bone marrow macrophages cultured on plastic dishes.  Supernatants of osteoclasts but not 
bone marrow macrophages stimulated the expression of Runx2 and osteocalcin in C2C12 
cells in concert with bone morphogenetic protein 2.  The expression of alkaline 
phosphatase was stimulated with supernatants of osteoclasts cultured on ceramic disks.  
These results suggested that osteoclasts produced certain soluble factors which stimulated 
osteoblastic differentiation and they were thought to be associated with the induction of a 
larger osteoblast surface and bone volume in the animals implanted with calcium-deficient 
HA granules. 
 




Osteoconductivity is the ability to provide an appropriate scaffold or template for bone 
formation [1].  Hydroxyapatite (HA) is known to express potent osteoconductivity and has 
been used clinically as a bone substitute.  HA is also known as a ceramic with an 
unbiodegradable nature when implanted into bone [2, 3], although a few reports have 
suggested that HA is resorbed in bone [4].  Beta-tricalcium phosphate (β-TCP) is another 
material frequently used as a bone substitute, and is expected to be replaced with bone 
tissue after implantation because of its biodegradable nature.  When the bone defect is 
large, the provision of osteogenic cells has been shown to improve the replacement of 
β-TCP to bone tissue, and tissue engineering, which differentiates mesenchymal stem cells 
to osteoblasts on a ceramic scaffold, is thought to be an effective methods for bone 
regeneration [5-10]. 
Although osteoinduction by ceramics has been shown experimentally, the data vary, the 
mechanism remains uncertain and no bone substitute with osteoinductive potential has been 
used clinically so far [11, 12]; however, stimulatory effects for osteogenesis may be present 
in some kinds of ceramics [12-14].  Yokozeki et al. initially suggested that the 
microstructure of β-TCP affected osteogenesis in implanted bone [15]. 
We have developed HA and β-TCP, composed of unique rod-shaped particles, using the 
applied hydrothermal method [16, 17].  The mineral apposition rate (MAR) in the region 
implanted with hydrothermally synthesized β-TCP composed of rod-shaped particles was 
significantly higher than β-TCP prepared by normal sintering [18].  Additionally, we have 
shown that the structure of particles composed of β-TCP affected not only osteogenesis in 
the implanted region but also the metabolism of newly formed bone, which was formed in 
place of β-TCP.  Recently, we implanted hydrothermally synthesized HA, composed of 
rod-shaped particles (HHA), to rabbit femurs as a bone substitute and showed that MAR in 
the region implanted with HHA was significantly higher than stoichiometric HA composed 
of globular-shaped particles, which were prepared by normal sintering (SHA) [19].  These 
data strongly suggested that the microstructures of ceramics affected the biological activity 
of osteoblasts.  In these experiments, HHA was biodegradable in implanted bone tissue, 
and higher MAR in specimens implanted with HHA might be associated with osteoclastic 
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resorption of HHA.  Biphagic calcium phosphate and octacalcium phosphate have also 
been shown to be resorbed by osteoclasts [20, 21].  In addition, it was shown that the 
amount of newly formed bone in the region implanted with biphagic calcium phosphate or 
octacalcium phosphate is more than that of HA using animal models [12, 22].  These data 
also supported that osteoclastic resorption of bone substitutes affected osteogenesis in the 
implanted region. 
Considering the clinical application of bone substitutes, a block-shaped bone substitute 
is thought to be useful for fixing of fractures and filling defects in heavily weighted regions 
of the bone.  On the other hand, granular bone substitutes should be useful for filling 
defects in unweighted or lightly-weighted regions of the bone.  Granular bone substitutes 
are easily applicable in many kinds of bone defects, and are expected to combine with the 
bone quickly, because there are many spaces which profit from the invasion of endothelial 
and osteoblastic cells around the granules; hence, the development of a granular bone 
substitute with a functional shape is also very important for clinical applications. 
Previously, we established a method to prepare unique spherical granules of HHA, SHA 
and β-TCP [23, 24].  In this study, we used originally developed spherical HHA and SHA 
granules as bone substitutes to fill bone defects created in rat tibiae; only HHA granules 
were biodegradable.  HHA granules had more osteoclasts on the surface than SHA and 
induced more bone tissue than spherical SHA granules in the implanted region.  The 
biological mechanism to increase osteogenesis by biodegradable ceramics remained 
uncertain; hence, this was studied by in vitro assay systems using osteoclasts and C2C12 
multipotent myoblastic cells.  By culturing C2C12 cells with supernatants of osteoclasts 




2. Materials and methods 
2.1. Preparation of ceramics 
Alpha-TCP powder (Taihei Chemical Ind. Co. Ltd., Saitama, Japan) was mixed and 
kneaded with 10% gelatine solution, and dropped into a stirred oil bath heated at 80 oC.  
The bath was then chilled on ice and spherical α-TCP/gelatine granules formed.  The 
granules were separated from the oil, rinsed and sintered at 1200 oC for 10 min to remove 
gelatine and to maintain the crystal phase of α-TCP.  The formed α-TCP granules were set 
in a 105 cm3 autoclave at 160 oC under saturated water vapour pressure for 20 h.  
Synthesized HHA granules were sieved and granules 0.5 to 0.6 mm diameter were used for 
experiments.  Spherical SHA granules were prepared by sintering at 900 oC for 3 h from 
the same chemical purity grade HA powders with stoichiometric composition.  The 
porosity of HHA and SHA granules was designed to be 70%.  Rod-shaped particles of 
spherical HHA granules (Fig. 1a, c) and globular-shaped particles of spherical SHA 
granules (Fig. 1 b, d) were confirmed using a scanning electron microscope.  Synthesized 
HHA and SHA granules were analyzed by powder X-ray diffractometry with 
graphite-monochromatized CuKα radiation, operating at 40 kV and 20 mA (XRD; Multi 
Flex, Rigaku, Tokyo, Japan).  No phase other than HA was detected for HHA and SHA 
(Fig. 1e, f).  When HHA was sintered at 1200 oC, decomposition of HA to β-TCP was 
detected because the HHA granules were nonstoichiometric HA of calcium-deficient 
composition.  There was no decomposition as a result of sintering in the case of SHA 
granules because SHA was stoichiometric (data not shown).  These results corresponded 
to chemical analysis by ICP-MS (SPQ9000; Seiko Inst., Tokyo, Japan). 
Disks for in vitro analyses were made by the sintering technique.  The slurry of β-TCP 
with polyvinyl alcohol was prepared at room temperature.  To remove bubbles, the slurry 
was kept under a vacuum.  The slurry was formed into a 25 mm diameter disk shape by 
uniaxial compressing.  The formed disks with polyvinyl alcohol were dried and sintered at 
900 ºC for 3 h to prepare β-TCP disks.  Some of the samples were set in an autoclave at 
160 oC under saturated water vapour pressure for 21 h to prepare HHA disks.  SHA disks 
were prepared from stoichiometric HA powder (Ube Material Industries Ltd., Yamaguchi, 
Japan) by normal sintering at 900 oC for 3 h in air.  Synthesized β-TCP, HHA and SHA 
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disks were also analyzed by powder X-ray diffractometry as described above, and the 
purity and uniformity of these materials were confirmed (data not shown). 
 
2.2. Animals and operative procedures 
Forty-eight female 8-week-old Wistar rats were anesthetized with an intraperitoneal 
injection of ketamine (40 mg/kg body weight) and xylazine (3 mg/kg body weight) before 
surgery.  Under sterile conditions, the proximal metaphysis and medial collateral ligament 
of the knee were exposed.  A dead-end bone defect 2 mm in diameter and 3 mm in depth 
was created in the medial cortex of the tibia just distal to the epiphyseal growth plate using 
a Kirschner’s wire.  The orientation of the defect was perpendicular to the sagittal axis of 
the tibia (Fig. 2a, b).  The defect was irrigated with saline, 30 mg HHA or SHA granules 
were implanted into the defect, and the wound was sutured layer by layer (Fig. 2c).  Four, 
8, 12 and 24 weeks after the operation, animals were euthanized, operated bones were 
resected and undecalcified bone tissue sections were made from the resected bones.  
Animals rearing and experiments were performed at the Biomedical Research Center, 
Center for Frontier Life Sciences, Nagasaki University, following the Guidelines for 
Animal Experimentation of Nagasaki University (Approval No. 0703010564, 
0704190571). 
 
2.3. Histological analyses 
All harvested tissue specimens were fixed in 4% formaldehyde in 0.1 M phosphate 
buffer (pH 7.2), embedded in 2-hydroxyethyl methacrylate/methyl 
methacrylate/2-hydroxyethyl acrylate mixed resin, and sectioned 3 μm thick.  These 
sections were stained by the method of Giemsa or histochemically stained for 
tartrate-resistant acid phosphatase (TRAP) activity or alkaline phosphatase (ALP) activity.  
TRAP activity was stained as described previously [25].  Staining for ALP activity was 
performed using 0.2 M Tris-HCl buffer (pH. 8.5) as a reaction buffer.  In this study, fast 
red RC salt (F5146; Sigma, St. Louis, MO) and fast blue BB salt (F3378; Sigma) were used 
as couplers to detect TRAP and ALP activities, respectively.  Sections stained for TRAP 




Histomorphometric analyses were performed using the Osteoplan II system (Carl Zeiss, 
Thornwood, NY).  In addition to parameters used under standardized nomenclature [26], 
original parameters were also used to calculate bone substitutes.  Bone volume + implant 
volume/tissue volume (BV+Imp.V/TV, %), implant volume/tissue volume (Imp.V/TV), net 
bone volume/tissue volume (BV/TV), osteoblast surface/bone surface (Ob.S/BS, %) and 
the number of osteoclasts/bone perimeter (N.Oc/B.Pm, per 100 mm) were calculated for 
each sample in a 0.6 mm x 1.8 mm square, which was aligned on the medial longitudinal 
axis of the tibia and arranged centrally in a created bone defect.  The change in implant 
volume per tissue volume was evaluated using a parameter Imp.V/TV, and displacement of 
the implant to newly formed bone was evaluated using a parameter BV/TV.  Osteoclasts 
were defined as multinucleated cells in contact with the bone or bone substitutes.  To 
calculate the parameters described above, sections stained with Giemsa’s method were used.  
Data are expressed as the mean ± s.d.  Statistical differences were evaluated with the t-test 
and P value < 0.05 was considered significant. 
 
2.4. In vitro experiments 
In vitro osteoclastogenesis was performed as follows.  Mouse bone marrow 
macrophages prepared from the femora and tibiae of 5-week-old female ddY mice were 
expanded in vitro in α-minimum essential medium supplemented with 10% fetal bovine 
serum and 30 ng/ml macrophage colony-stimulating factor (Sigma).  The macrophages (1 
x 104 cells/cm2) were mixed with NIH3T3 cells expressing human RANKL cDNA (1 x 104 
cells/cm2) [25], and seeded in 6-well plates into which one β-TCP, SHA or HHA disk of 25 
mm diameter was inserted.  All ceramic disks were presoaked in α-minimum essential 
medium supplemented with 10% fetal bovine serum for 3 weeks before being used for 
experiments.  The soaking medium was changed twice a week.  The medium of the 
cultures was changed every other day up to day 18 of the culture period.  Culture 
supernatants of numerous osteoclasts at 8, 10 and 12 days of culture were collected, stored 
at 4 ºC and used for the following experiments.  In addition, a culture supernatant of 
osteoclasts cultured as described in plates without a ceramic disc and a culture supernatant 
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of mouse bone marrow macrophages were also used for experiments. 
C2C12 myoblastic cells, which possess the potential to differentiate into osteoblasts 
when stimulated with bone morphogenetic protein 2 (BMP-2) [27], were cultured in 60% 
Dulbecco’s minimum essential medium including 2.5% fetal bovine serum and 40% of 
each culture supernatant supplemented with 200 ng/ml BMP-2 (R&D Systems, CA).  As a 
control, α-minimum essential medium supplemented with 10% fetal bovine serum was used 
in place of the culture supernatant.  The calcium concentration in each mixed culture 
medium was analyzed using a JCA-BM12 automatic analyzer (JEOL, Tokyo, Japan) and 
Diacolor Liquid Ca Kit (Toyobo, Osaka, Japan) following routine biochemical examination 
in Nagasaki University Hospital. 
Real-time PCR was performed using cDNA synthesized from total RNA extracted from 
C2C12 cells described above with Premix EX-Taq (TAKARA, Shiga, Japan) and a Mx 
3005P QPCR System (Stratagene, CA) following the manufacturer’s instructions.  Primers 
used for the PCR reaction were as follows: Runx2: Mm00501580_m1, Alkaline 
phosphatase (ALP): Mm00475834_m1, Osteocalcin: Mm03413826_mH, Gapdh: 
Mm99999915_g1 (all from Applied Biosystems, CA).  Values for each gene were 
normalized to the relative quantity of glyceraldehyde-3-phosphate dehydrogenase mRNA in 
each sample.  Data were evaluated using the t-test with data from 4 identical experiments 




3.1. Histological analyses 
Light microscopic views of specimens stained with Giemsa’s method are shown in Fig. 
3.  Implanted materials appeared dark and were distinguishable from bright bone tissue 
and blue-stained bone marrow tissue including scattered whitish adipose tissue and dark 
blue-stained fibrous tissues (arrows).  In specimens implanted with HHA (Fig. 3a−d) and 
SHA (Fig. 3e−h), a large amount of implants could be recognized and mosaic hard tissue 
composed of implanted granules and bone tissue was formed.  It was clear that a large 
amount of bone tissue formed around implants from 4 weeks after the operation in 
specimens implanted with HHA and SHA.  The total amount of the hard tissue including 
implants and newly formed bone, was much larger than the surrounding trabecular bones 
(Fig. 3).  Additionally, in specimens 4, 8 and 12 weeks after implantation of HHA, 
connective tissue composed of fibroblastic cells was seen (Fig. 3a−c, arrows).  This was 
also observed around SHA granules in some specimens, although no photograph is shown.  
After combining with the bone, both HHA and SHA granules tended to be broken down 
into smaller round pieces and this tendency become greater in later stages after the 
operation (Fig. 3c, d, g, h). 
Interestingly, in some portions of residual HHA and SHA granules 12 and 24 weeks 
after the operation, composites of ceramic particles and bone tissue were formed (Fig. 4a).  
Arrowheads indicate the border between an implanted HHA granule and surrounding bone 
tissue.  Figure 4b shows the histological findings of an implanted HHA granule without 
bone inclusion.  Numerous fine rod-shaped particles were seen. 
 
3.2. Histochemical analyses 
The activities of one of the biochemical markers for osteoclasts, TRAP, and one of the 
biochemical markers for osteoblasts, ALP, were analyzed histochemically.  Many 
TRAP-positive multinucleated cells were observed on the surface of implants and bone 
tissue throughout the experimental period in specimens implanted with HHA and SHA 
(Figs. 5 and 6, a−d).  On the surface of HHA, relatively large decay (Fig. 5a, arrows) and 
resorption lacunae-like structures (Fig. 5b−d, arrows) were frequently seen.  This surface 
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decay was more obvious in HHA than in SHA, but surface irregularity of the implants was 
also seen in SHA to some extent and was sometimes difficult to distinguish from resorption 
lacunae (Fig. 6a, b, arrows).  ALP-positive cells were detected on the surface of bone 
tissue (Fig. 5g, h, Fig. 6e−h, arrowheads).  ALP-positive cells were also observed in the 
bone marrow area (Fig. 5f, arrows).  The fibroblastic cells shown in Fig. 3a−c (arrows) 
were ALP-positive, and ALP activity in Fig. 5f is a higher magnification view of some of 
these cells.  Once residual implants were combined with newly formed bone, osteoclasts 
and osteoblasts were found in only small bone marrow spaces, including small blood 
vessels (Figs. 5d, h, 6c, d, g, h). 
 
3.3. Histomorphometry 
BV+Imp.V/TV was maintained almost equally and was not significantly different 
between specimens implanted with HHA and SHA throughout the experimental period (Fig. 
7a).  The net implant volume was evaluated by Imp.V/TV, tended to gradually decrease in 
specimens implanted with HHA, and was significantly lower than specimens implanted 
with SHA 12 and 24 weeks after the operation (Fig. 7b).  To evaluate the displacement of 
the implant to newly formed bone, BV/TV was calculated, tended to gradually increase in 
specimens implanted with HHA, and was significantly higher than specimens implanted 
with SHA 12 and 24 weeks after the operation (Fig. 7c).  The composite composed of 
bone and HHA or SHA (Fig. 4a) was included in “Imp.V” when histomorphometric 
analyses were performed.  Both Ob.S/BS and N.Oc/B.Pm tended to be higher in 
specimens implanted with HHA than in specimens implanted with SHA throughout the 
experimental period.  Ob.S/BS and N.Oc/B.Pm in specimens implanted with HHA were 
significantly higher than SHA 12 and 24 weeks after the operation and 4, 8 and 24 weeks 
after the operation, respectively (Fig. 7d, e). 
 
3.4. In vitro analyses 
C2C12 myoblastic cells, which differentiate into osteoblastic cells in the presence of 
BMP-2, were cultured using supernatants of osteoclasts cultured on β-TCP, SHA, HHA or 
plastic dishes, or using a supernatant of bone marrow macrophages cultured on plastic 
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dishes.  Except for a culture medium including 40% of the supernatant of osteoclasts 
cultured on SHA, the calcium concentration in each medium ranged from 7.56 to 7.78 
mg/dl, which was similar to that in control medium, including 40% of fresh α-minimum 
essential medium supplemented with 10% fetal bovine serum.  Only the calcium 
concentration of the medium, including 40% of culture supernatant of osteoclasts cultured 
on SHA, was lower than the others (Fig. 8a).  These supernatants did not affect the 
expression of Runx2, osteocalcin or ALP in C2C12 cells in the absence of BMP-2 (data not 
shown).  The stimulatory effect of these culture supernatants on these expressions in 
C2C12 cells was then assessed in the presence of a low level (200 ng/ml) of BMP-2.  As 
shown in Fig. 8b, the expression of Runx2 was significantly increased in C2C12 cells 
cultured with media including any kind of supernatants of osteoclasts compared to C2C12 
cells cultured with medium including the supernatant of bone marrow macrophages or 
control medium including fresh α-minimum essential medium in place of the culture 
supernatant.  The expression of Runx2 in C2C12 cells cultured with the supernatant of 
bone marrow macrophages was almost the same level as the control, and no significant 
difference was detected in the expression of Runx2 in C2C12 cells cultured with any 
supernatant of osteoclasts (Fig. 8b). 
Osteocalcin was highly expressed in C2C12 cells cultured with supernatants of 
osteoclasts cultured on ceramic disks.  Statistical analyses indicated that the expression of 
osteocalcin was significantly higher in C2C12 cells cultured with any supernatant than the 
control.  The expression of osteocalcin in C2C12 cells cultured with the supernatant of 
osteoclasts on plastic dishes was significantly higher than the supernatant of bone marrow 
macrophages, and the expression of osteocalcin in C2C12 cells cultured with the 
supernatant of osteoclasts on β-TCP or SHA disks was significantly higher than the 
expression in C2C12 cells cultured with the supernatant of osteoclasts on plastic dishes (Fig. 
8c).  The expression of osteocalcin in C2C12 cells cultured with the supernatant of HHA 
tended to be higher than the expression in C2C12 cells cultured with the supernatant of 
osteoclasts on plastic dishes, although it was not significant (Fig. 8c).  The expression of 
osteocalcin in C2C12 cells cultured with the supernatant of macrophages was significantly 
higher than that of the control (Fig. 8c). 
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ALP was highly expressed only in C2C12 cells cultured with supernatants of osteoclasts 
cultured on ceramic disks.  In these cells, the expression of ALP was significantly higher 
than that in C2C12 cells cultured with the supernatant of osteoclasts on plastic dishes, with 
the supernatant of bone marrow macrophages, and cultured with control medium.  The 
expression of ALP in C2C12 cells cultured with the supernatant of osteoclasts on plastic 
dishes and cultured with a supernatant of bone marrow macrophages was not significantly 




We have already reported that cylindrical HHA blocks 6 mm in diameter and 10 mm in 
length slowly biodegraded in the rabbit femur [19].  In the present study, we confirmed 
that spherical HHA granules also slowly biodegraded in the rat tibia.  Granules have 
advantages in that they are widely applicable to various bone defects, and have much more 
surface area than a block when filled in an equivalent bone defect, and intergranular space 
is thought to benefit bone tissue invasion.  Additionally, our uniform-sized spherical 
granules were thought to have advantages to achieve stable and better prognosis than 
irregular-shaped granules, as suggested previously [24]. 
Although the biodegradability of HHA granules was slow (Fig. 7b), HHA blocks 
implanted in rabbit femurs were mostly resorbed 72 weeks after implantation and replaced 
with bone tissue.  This finding was strikingly different from SHA implants, which almost 
completely remained [19].  Considering these previous findings in rabbit experiments, the 
remaining HHA granules, which formed mosaic tissue composed of HHA and bone tissue 
up to 24 weeks after the operation, were thought to express modest biodegradability and 
were expected to be replaced with bone tissue over a longer period.  Additionally, mosaic 
tissue composed of bone and HHA or SHA granules was thought to have higher mechanical 
strength than the ceramic itself, and slow biodegradability of HHA may not be a serious 
problem when applied for clinical treatment, although precise studies to analyze the 
mechanical strength of mosaic tissue are needed.  Using a rabbit implantation model, we 
showed that the implantation of a bone substitute with excess biodegradability corrupted 
normal bone metabolism and caused the resorption of regenerated bone formed in place of 
the bone substitute [18].  Hence, the slow biodegradability of HHA granules might not be 
a disadvantage for clinical application. 
In this study, we found a composite composed of ceramic with bone inclusion (Fig. 5a).  
One of the mechanisms of composite formation was thought to be the invasion of bone 
tissue from macropores of the ceramic.  Another possibility was suspected to be increased 
local calcium concentration by degradation of the ceramic.  Although the composite, 
which was seen in both HHA and SHA, was formed irrespective of the biodegradability of 
the ceramic, the calcium concentration of the supernatant of osteoclasts cultured on SHA 
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was lower than the others (Fig. 8a), and SHA was thought to have the ability to adsorb 
calcium.  This calcium adsorption might contribute to composite formation in SHA.  
Analyses of the physical nature of the composite and in vitro study using body fluids are 
also needed. 
Bone metabolism is strictly regulated.  Under physiological conditions, the amount of 
bone formation and bone resorption are regulated to be equal.  Hence, it has been 
hypothesized that osteogenesis and osteolysis influence each other to maintain the 
homeostasis of bone metabolism.  The expression of one of the most important factors for 
osteoclastogenesis, RANKL by osteoblasts induces osteoclastogenesis and reveals the 
regulation of osteolysis by osteogenic cells [28].  It has been suggested that certain 
proteins included in bone were released by osteoclastic bone resorption and contributed to 
osteogenesis [18, 19, 22].  Osteoclasts might also directly contribute to osteogenesis 
through increased local calcium concentration and still unknown functions.  Interestingly, 
osteoclasts were recognized not only on HHA but also on SHA for a relatively long period, 
but N.Oc/B.Pm in the implanted area of HHA was significantly higher than that of the 
implanted area of SHA.  In addition to the biodegradability of HHA granules, we detected 
significantly more bone formation in the region implanted with HHA granules compared to 
the region implanted with SHA granules (Fig. 7a).  These data also raised the possibility 
of osteoclastic stimulation of osteogenesis. 
We tried to clarify whether osteoclasts affected the differentiation of osteoblasts using 
an in vitro assay system of osteoclastogenesis and osteoblastic differentiation.  In this 
study, we showed for the first time that certain soluble factor(s) in culture supernatants of 
osteoclasts stimulated the differentiation of osteoblasts (Fig. 8).  Although culture 
supernatants of osteoclasts did not solely differentiate osteoblasts, they stimulated the 
expression of Runx2 and osteocalcin in C2C12 cells in concert with BMP-2.  These data 
showed that the soluble factor(s) in culture supernatants was other than BMP-2.  It was of 
interest that the stimulatory effects of supernatants of osteoclasts were influenced by the 
culture condition.  The Runx2 binding domain is present in the promoter region of the 
osteocalcin gene and the expression of Runx2 directly affects the expression of osteocalcin.  
In this study, supernatants of any osteoclasts evenly stimulated the expression of Runx2, 
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but supernatants of osteoclasts cultured on ceramic disks stimulated the differentiation of 
C2C12 cells more potently than that of a supernatant of osteoclasts cultured on plastic 
dishes.  These data suggest that osteoclasts cultured on ceramic disks preferentially 
express factors other than Runx2 which stimulate the differentiation and maturation of 
osteoblasts.  The influence of supernatants of osteoclasts on ALP expression was more 
striking.  The expression of ALP was significantly higher only in C2C12 cells cultured 
with supernatants of osteoclasts cultured on ceramic disks (Fig. 8c).  The biological 
difference between osteoclasts cultured on ceramic disks and on plastic dishes has not been 
characterized precisely.  Osteoclasts cultured on ceramic disks were thought to actually 
resolve β-TCP and HHA, and to try to resolve SHA.  Hence, it was highly possible that 
osteoclasts on these ceramics were more biologically active than osteoclasts on plastic disks 
in the activity of proton ATPase, calcium channels, calcium pumps and so on, and certain 
soluble factors which stimulate the expression of ALP might be synthesized only in active 
osteoclasts. 
We have suggested that the structure of rod-shaped particles of our ceramics also 
affected osteogenesis, although the precise biological mechanism remains uncertain [18, 
19].  Additionally, rod-shaped particles composed of HHA have polarity with a prolonged 
c-axis, and the surface was thought to have many positive-charged sites.  The preferential 
adsorptive nature of HHA for acidic protein [29] also supports this hypothesis.  The 
surface charge of ceramics was suggested to stimulate osteogenesis [30, 31], and not only 





We have established a unique method to make spherical granules of calcium-deficient 
HA composed of rod-shaped particles (HHA) using an applied hydrothermal method.  
HHA granules biodegraded by osteoclastic resorption in contrast to spherical granules of 
stoichiometric HA (SHA).  Histomorphometric analyses showed that the number of 
osteoclasts and the amount of newly formed bone were significantly increased in the 
specimens implanted with HHA compared to SHA.  In vitro studies showed that the 
supernatants of osteoclasts stimulated the expression of Runx2 and osteocalcin, and 
supernatants of osteoclasts cultured on HHA, SHA and β-TCP disks, but not plastic dishes, 
stimulated the expression of ALP in C2C12 multipotent myoblastic cells in the presence of 
BMP-2.  In vitro studies suggested that osteoclasts produced certain soluble factor(s) 
which stimulate osteoblastic differentiation, and osteoclasts cultured on HHA, SHA and 
β-TCP synthesized distinct soluble factor(s) which stimulate the expression of ALP in 
C2C12 cells.  A composite composed of ceramic with bone inclusion was shown to be 
formed in both implanted HHA and SHA granules.  The composite was thought to be 
formed by the invasion of bone tissue into macropores of porous ceramics, but increased 
local calcium concentration by HHA degradation and the calcium adsorptive nature of SHA 
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Fig. 1.  Scanning electron micrographs of the overview (a, b) and the microstructure (c, d) 
of HHA (a, c) and SHA (b, d) granules.  (e, f) X-ray diffractometry (XRD) of implants 
used in this study.  XRD patterns of HHA (e) and SHA (f) granules. 
 
Fig. 2.  Schematic drawings of anterior-posterior view (a) and lateral view (b) of the 
operated proximal tibia.  (c) Photographic view of the created bone defect and implanted 
granules. 
 
Fig. 3.  Histological appearance of undecalcified sections of rat tibiae implanted with 
HHA (a−d) and SHA (e−h).  Sections were stained by Giemsa’s method.  Arrows 
indicate fibrous connective tissue formed around implants. 
 
Fig. 4.  High-power magnification views of composite formed in an implanted HHA 
granule (a) and a residual HHA granule implanted into bone (b).  Arrowheads represent 
the border between an implanted granule and surrounding bone tissue.  Asterisks (*) 
represent bone tissue.   Sections were stained with hematoxylin and viewed using 
polarization filters. 
 
Fig. 5.  Histochemical appearance of undecalcified sections of rat tibiae implanted with 
HHA stained for TRAP activity (a−d) and for ALP activity (e−h).  Arrows in a−d indicate 
the surface of resorption lacunae-like decay found on HHA granules.  Arrows in f indicate 
ALP-positive cells in the bone marrow area and arrowheads in g and h indicate 
ALP-positive osteoblasts on the surface of bone tissue or implants. 
 
Fig. 6.  Histochemical appearance of undecalcified sections of rat tibiae implanted with 
SHA stained for TRAP activity (a−d) and for ALP activity (e−h).  Arrows in a−d indicate 
decay found on the surface of SHA granules.  Arrowheads indicate ALP-positive 




Fig. 7.  Histomorphometry of implants and bone tissue in specimens 4, 8, 12 and 24 
weeks after the operation.  Parameters of the amount of implants and bone tissue for the 
amount of total tissue, BV+Imp.V/TV (a), the net amount of implants for the amount of 
total tissue, Imp.V/TV (b) and the net amount of newly formed bone for the amount of total 
tissue, BV / TV (c) were compared between specimens implanted with HHA (dark gray 
columns) and specimens implanted with SHA (light gray columns).  Parameters for 
osteoblasts, Ob.S/B.S (d) and for osteoclasts, N.Oc/B.Pm (e) were also compared.  Six 
samples for each experiment were analyzed for the acquired data.  (*P < 0.05, **P < 0.01) 
 
Fig. 8.  In vitro differentiation of C2C12 cells with culture supernatants of osteoclasts.  
(a) Calcium concentration of media using this assay.  Beta-TCP, SHA and HHA represent 
medium including 40% of osteoclast supernatant cultured on β-TCP disks, HHA disks and 
SHA disks, respectively.  Plastic represents medium including 40% of osteoclast 
supernatant cultured on dishes without ceramic disks.  Mph represents medium including 
40% of bone marrow macrophage supernatant, and Control represents medium including 
40% of fresh culture medium for osteoclasts.  (b−d) Real-time PCR analyses for the 
expression of osteoblast markers.  Relative quantity of Runx2 (b), osteocalcin (c) and ALP 
(d) mRNA expression.  The β-TCP, SHA, HHA, Plastic, Mph and Control represent 
C2C12 cells cultured with each supernatant described above, respectively.  (*P < 0.05, 
**P < 0.01) 
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